Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB)
CUSIP: 98887Q104
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.000006 per share
- Shares outstanding
- 1,104,525,577
- Total 13F shares
- 45,281,591
- Share change
- +4,775,913
- Total reported value
- $1,092,880,285
- Put/Call ratio
- 264%
- Price per share
- $24.14
- Number of holders
- 102
- Value change
- +$127,670,248
- Number of buys
- 51
- Number of sells
- 48
Quarterly Holders Quick Answers
What is CUSIP 98887Q104?
CUSIP 98887Q104 identifies ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98887Q104:
Top shareholders of ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.65%
|
7,124,491
|
$123,467,429 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.59%
|
6,527,567
|
$113,125,366 | — | 30 Jun 2024 | |
| Capital World Investors |
13F
|
Company |
0.48%
|
5,307,939
|
$91,986,583 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.21%
|
2,332,684
|
$40,425,414 | — | 30 Jun 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.18%
|
2,037,374
|
$35,307,691 | — | 30 Jun 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.16%
|
1,792,651
|
$31,066,642 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.15%
|
1,657,915
|
$28,733,000 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.12%
|
1,297,873
|
$22,492,139 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0.1%
|
1,132,061
|
$19,618,618 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
899,666
|
$15,591,211 | — | 30 Jun 2024 | |
| Capital International Investors |
13F
|
Company |
0.07%
|
805,878
|
$13,965,866 | — | 30 Jun 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.07%
|
792,815
|
$13,739,484 | — | 30 Jun 2024 | |
| Fu Tao |
3/4/5
|
President & COO, Director |
—
class O/S missing
|
265,168
|
$13,303,479 | — | 28 Oct 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
660,587
|
$11,447,973 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
543,814
|
$9,424,312 | — | 30 Jun 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
0.05%
|
531,198
|
$9,205,661 | — | 30 Jun 2024 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.05%
|
521,825
|
$9,043,227 | — | 30 Jun 2024 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.05%
|
500,000
|
$8,665,000 | — | 30 Jun 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.04%
|
478,621
|
$8,294,502 | — | 30 Jun 2024 | |
| BRILLIANCE ASSET MANAGEMENT LTD |
13F
|
Company |
0.04%
|
436,527
|
$7,565,013 | — | 30 Jun 2024 | |
| M&G Plc |
13F
|
Company |
0.04%
|
437,265
|
$7,433,505 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.03%
|
365,013
|
$6,325,380 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
295,959
|
$5,128,969 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
244,522
|
$4,237,567 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
221,970
|
$3,846,740 | — | 30 Jun 2024 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.02%
|
215,789
|
$3,748,255 | — | 30 Jun 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.02%
|
215,178
|
$3,729,035 | — | 30 Jun 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.02%
|
214,777
|
$3,722,085 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
183,507
|
$3,180,176 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
174,039
|
$3,016,096 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
161,485
|
$2,798,535 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
156,284
|
$2,710,721 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.01%
|
144,460
|
$2,503,492 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
127,507
|
$2,209,696 | — | 30 Jun 2024 | |
| FIL Ltd |
13F
|
Company |
0.01%
|
125,941
|
$2,182,558 | — | 30 Jun 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.01%
|
124,096
|
$2,150,584 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
117,224
|
$2,031,492 | — | 30 Jun 2024 | |
| Alan B. Sandler |
3/4/5
|
Head of Global Dev., Oncology |
—
class O/S missing
|
73,000
|
$1,906,906 | — | 25 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
105,003
|
$1,819,702 | — | 30 Jun 2024 | |
| Harald Reinhart |
3/4/5
|
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases |
—
mixed-class rows
|
206,440
mixed-class rows
|
$1,774,330 | — | 25 Jun 2024 | |
| William Ki Chul Cho |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
61,378
mixed-class rows
|
$1,603,316 | — | 03 Apr 2023 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.01%
|
86,904
|
$1,511,059 | — | 30 Jun 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.01%
|
86,700
|
$1,502,511 | — | 30 Jun 2024 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.01%
|
79,642
|
$1,380,196 | — | 30 Jun 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
72,520
|
$1,256,772 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.01%
|
70,283
|
$1,218,004 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
65,888
|
$1,141,839 | — | 30 Jun 2024 | |
| AXA S.A. |
13F
|
Company |
0.01%
|
65,814
|
$1,140,557 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.01%
|
55,914
|
$968,990 | — | 30 Jun 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0%
|
55,000
|
$953,150 | — | 30 Jun 2024 |
Institutional Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q3 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.